Lymphoproliferative Disorders
📧 Sign up to get email alerts when something new happens for Lymphoproliferative Disorders.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases [Phase 2]
Phase 2 clinical trial evaluating tabelecleucel in EBV-associated diseases is active/not recruiting, focusing on EBV+ LPD and related condit…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation [Phase 2]
A Phase 2 study evaluating allogeneic hematopoietic cell transplantation for disorders of T-cell proliferation and/or dysregulation, sponsor…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: Virtual Rehabilitation for Cancer Survivors [NA]
A clinical trial update indicates a virtual rehabilitation program for cancer survivors is currently recruiting across multiple cancer types…
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases [Phase 2]
This Phase 2 clinical trial update reports that the study evaluating Tabelecleucel for Epstein-Barr virus–associated diseases is currently r…
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition [Phase 2, Phase 3]
The update notes ongoing recruitment for the DETERMINE trial Arm 02 investigating atezolizumab in adults and pediatric/young adult patients …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-19Clinical Trial Update: Treatment and Natural History Study of Lymphomatoid Granulomatosis [Phase 2]
This is a Phase 2 clinical trial update reporting results for a treatment and natural history study of lymphomatoid granulomatosis; results …
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: Dose Escalation & Expansion Study of Oral VRx-3996 & Valganciclovir in Subjects With EBV+ Lymphoid Malignancies [Phase 1, Phase 2]
Phase 1/2 dose-escalation and expansion study of VRx-3996 with valganciclovir in Epstein-Barr virus-associated lymphoma and other EBV-relate…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: Plerixafor Harvesting And No Chemotherapy for Transplantation of Autologous STem Cells In Cancer (PHANTASTIC) [NA]
The PHANTASTIC trial evaluating plerixafor-assisted, chemotherapy-free autologous stem cell transplantation for cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-12-10Clinical Trial Update: CAR-NK Cells Production and Expansion From Patients With Lympho or Myeloproliferative Disorders and From Healthy Donors [NA]
Clinical trial update on producing and expanding CAR-NK cells from patients with lymphoproliferative or myeloproliferative disorders and fro…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases [NA]
This ClinicalTrials.gov update reports on a completed study evaluating whether music can reduce anxiety and pain in adults undergoing bone m…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: VNP40101M in Treating Patients With Richter Syndrome or Refractory or Relapsed Chronic Lymphocytic Leukemia or Other Lymphoproliferative Disorders [Phase 1, Phase 2]
Phase 1/2 trial of VNP40101M for Richter syndrome and refractory/relapsed chronic lymphocytic leukemia or other lymphoproliferative disorder…
-
CLINICAL_TRIALS trial_result · 2012-08-09Clinical Trial Update: Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB) [Phase 1, Phase 2]
Clinical trial update on a reduced-intensity preparative regimen followed by stem cell transplantation (FAB) in several hematologic malignan…
-
CLINICAL_TRIALS trial_result · 2012-07-19Clinical Trial Update: A Phase I Trial of ZIO-101 in Hematologic Cancers [Phase 1]
This document reports the completion status of a Phase I trial evaluating ZIO-101 in hematologic cancers sponsored by Alaunos Therapeutics.
-
CLINICAL_TRIALS trial_result · 2011-08-01Clinical Trial Update: Study of Arginine Butyrate and Ganciclovir/Valganciclovir in EBV(+) Lymphoid Malignancies [Phase 2]
Phase 2 trial evaluating arginine butyrate with ganciclovir/valganciclovir in Epstein-Barr virus-associated lymphoid malignancies was termin…
-
CLINICAL_TRIALS trial_result · 2011-08-01Clinical Trial Update: Study of HQK-1004 and Valganciclovir to Treat Epstein-Barr Virus (EBV) - Positive Lymphoid Malignancies or Lymphoproliferative Disorders [Phase 2]
A Phase 2 study of HQK-1004 in combination with valganciclovir for Epstein-Barr virus–associated lymphoid malignancies and lymphoproliferati…
-
CLINICAL_TRIALS trial_result · 2010-10-21Clinical Trial Update: Bendamustine and Rituximab As Salvage Therapy In Patients With Chronic Lymphoproliferative Disorders
The clinical trial update reports on salvage therapy with bendamustine and rituximab in patients with relapsed or refractory chronic lymphop…
-
CLINICAL_TRIALS trial_result · 2010-01-13Clinical Trial Update: Detection and Cytotoxic T Lymphocyte Therapy of Post-Transplant Lymphoproliferative Disorder After Liver Transplant [Phase 1]
Phase 1 clinical trial evaluating cytotoxic T lymphocyte therapy for post-transplant lymphoproliferative disorder after liver transplantatio…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: A Pilot Study of the Combination of Retinoic Acid and Interferon-Alpha2a for the Treatment of Lymphoproliferative Disorders in Children With Immunodeficiency Syndromes [Phase 2]
A completed Phase 2 pilot trial evaluating the combination of all-trans retinoic acid and interferon-alpha2a for lymphoproliferative disorde…
-
CLINICAL_TRIALS trial_result · 2007-06-14Clinical Trial Update: Trial of MEDI-507 in CD2-Positive Lymphoproliferative Disease [Phase 1]
Phase 1 trial of MEDI-507 for CD2-positive lymphoproliferative disease has been terminated.